Milatz, Florian
Voigt, Lisa
Klotsche, Jens
Tomczyk, Samuel
Kallinich, Tilmann
Trauzeddel, Ralf
Windschall, Daniel
Hansmann, Sandra
Baumeister, Nadja
Haas, Johannes-Peter
Klaas, Moritz
Girschick, Hermann
Peitz-Kornbrust, Joachim
Böhm, Peter
Wiegand, Julius
Willich, Stefan N.
Burchartz, Alexander
Minden, Kirsten
Funding for this research was provided by:
Deutsches Rheuma-Forschungszentrum Berlin (DRFZ)
Article History
Received: 17 June 2025
Accepted: 8 December 2025
First Online: 17 December 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and the principles of Good Clinical Practice. The ActiMON study (IRB approval number: EA2/204/20) and the NPRD registry (IRB approval number: EA1/044/07) were approved by the ethics committee of Charité – Universitätsmedizin Berlin and the relevant regional ethics boards of all participating centers. Written informed consent was obtained from all participants and/or their legal guardians, depending on age and local legal requirements.
: Not applicable.
: The authors declare no competing interests.